Acquired Amegakaryocytic Thrombocytopenia Associated With Autoimmune Hemolytic Anemia

Cureus. 2022 Jul 26;14(7):e27315. doi: 10.7759/cureus.27315. eCollection 2022 Jul.

Abstract

Acquired amegakaryocytic thrombocytopenia (AATP) is a thrombocytopenic disorder characterized by a decrease in megakaryocytes in the bone marrow. AATP is effectively treated with immunosuppressive therapy. We report a case of a 68-years-old male referred to us due to purpuric lesions on the extremities and was noted to be thrombocytopenic. Bone marrow biopsy showed AATP with autoimmune hemolytic anemia (AIHA). Only two cases of AATP associated with AIHA have been reported. AATP should be differentiated carefully from other causes of peripheral destruction of platelets, such as immune thrombocytopenia (ITP).

Keywords: amegakaryocytic thrombocytopenia; autoimmune disease; autoimmune hemolytic anemia; thrombocytepenia; thrombopoietin.

Publication types

  • Case Reports